Connect with us

National

‘Anguish, pain’: Matabeleland North’s chronically ill choke under govt neglect

Published

on

BY NOKUTHABA DLAMINI

Two months ago, cervical cancer claimed the life of her sister.

Advertisement

Now, 41-year-old Olidah Ngulube, is battling breast cancer, bed-ridden at her late sister’s home in the Singwangombe village of Nkayi in Matabeleland North province.

In Victoria Falls, 51-year-old Mildred Mhlanga, is battling the same disease, which has resulted in her being diagnosed with a severe heart problem after undergoing successful chemotherapy as the cancer had reached stage four of the deadly disease, being the advanced stage.

“I hardly sleep at night as the pain sharpens and l often cry with very little help as my family does not know how to assist me,”  says a visibly anguished Ngulube.

Advertisement

Ngulube has not been able to go to Mpilo Central Hospital in Bulawayo where she was referred to by Nkayi nurses for her to be examined by a specialist.

She fears that just like her sister who succumbed to the same disease, and with the collapsing health system in the country coupled with prolonged lockdowns to slow down the spread of Covid-19, her chances of survival are slowly becoming slim.

Ngulube said: ” I started feeling some lumps and severe pains on my left breast when my sister died, but at hospital they told me that for me to be able to be treated, I will need money in United States dollars for the first tablets, consultation, and examination before the chemotherapy process on top of transport money to Bulawayo. I don’t have it and that’s why l am in this anguish. I don’t have money for treatment.”

Advertisement

Breast cancer has become Zimbabwe’s new health headache, and it is not alone, having teamed up with cervical cancer, becoming the poor country’s tense disease in the health sector.

“I’m in pain, dying is better, I wait for my day to rest from this pain,” fragile and visibly thin Mhlanga said as she winced in pain, lying in bed in her room while her eyes were watery.

For any cancer patient like Mhlanga, what decides the treatment depends on the stage of the cancer

Advertisement

For her, even though she successfully finished her three-year-long chemotherapy in February this year, she had had to face yet another severe disease being the side effects of the treatment process.

“I was supposed to go for my right breast removal, but I’ll not be able to do so because I am now on a new treatment for a heart problem,”

“When I visited the doctors in Bulawayo, they told me that those are side effects of chemotherapy so I’m now on twin medications that l need to purchase at US$30 each per month.”

Advertisement

 

Battles on two fronts

Statistics from the Zimbabwe Vulnerability Assessment Committee (ZimVac) 2021 Rural Livelihoods Committee Assessment Report revealed a shocking pattern about the high disease burden in Matabeleland North province.

Advertisement

For example, the province has the highest proportion of household members with HIV/Aids at 42.4 percent against a national average of 3.2 percent. The province also has some of the highest percentages of people with chronic illnesses that are missing their medication.

 

In 2017, the World Health Organization (WHO) announced that the number of annual cancer deaths globally reached at 8.2 million, adding that the numbers were expected to triple by 2030.

With breast and cervical cancers as the country’s twin evils haunting hundreds of women like Ngulube and Mhlanga, the Health and Child Care ministry says approximately 1 500 women are succumbing to cervical cancer each year.

Advertisement

Not only that, but Zimbabwe’s Cancer Association also says breast cancer alone is claiming more than one thousand women every year.

Even health experts in the country concur that cervical and breast cancer have wreaked havoc in Zimbabwe.

 

Advertisement

Who is responsible?

Women rights activists have blamed the government for the deaths of their colleagues from cancer and other chronic illnesses.

“Government is solely responsible for the lack of service in hospitals especially in Matabeleland North and that means cancer patients are at the receiving end of the crisis in hospitals, “Fungisai Sithole from Citizen Health Watch said.

Advertisement

” What has worsened their plight even more is the government’s total neglect of critical illnesses in favour of Covid-19 and people are dying with little help at sight.”

For instance, all hospitals and clinics, including in resort cities like Victoria Falls, have no theatre for chemotherapy.

Patients must travel over 500 kilometers to reach the nearest facility at Mpilo Central Hospital, hence a few manage to take that route, Sithole noted.

Advertisement

According to the United Nations Office for the Coordination of Humanitarian Affairs (OCHA), outpatient consultations at public hospitals in Zimbabwe declined by 36 percent between April and July compared to the same period in 2019.

Is the government committed to fund hospitals?

Itai Rusike, the executive director of the Community Working Group on Health (CWGH), a network of community groups, said the upsurge in chronic illnesses and the advent of Covid-19 had put pressure on a health delivery system already weakened by over dependence on donors, intermittent strikes by doctors and nurses and minimal investment from the government.

Advertisement

“Covid-19 has been a wakeup call for countries with weaker health systems, especially those that have been relying on global donor funding, and this is what we are witnessing in Zimbabwe,” Rusike said.

He explained that Zimbabwe’s national budget in the past has seen very little money being allocated towards health and relied on donors.

“This left the country more vulnerable and exposed to disease outbreaks,” he said.

Advertisement

Last year, Zimbabwe’s budget allocation for health was US$4.80 per capita, almost 90% lower than the US$36 advised by the World Health Organisation (WHO), leaving many public health facilities without medicines.

The inadequate budgetary support has also been blamed for the brain drain in the health sector with doctors and nurses leaving for better paying jobs in other countries.

Rusike said when Covid-19 arrived, the country immediately shifted its focus wholly towards the pandemic.

Advertisement

“This is why we are witnessing more and more numbers of malaria deaths and maternal deaths alongside rising HIV and Tuberculosis cases,” he said.

The number of new coronavirus infections had been declining since August, leading to the relaxation of strict lockdown restrictions, but the crisis in the health sector and the emergence of the new Covid-19 Omicron variant is far from over.

Strikes, poor remuneration ground hospitals

Advertisement

Public hospitals are struggling in Zimbabwe because apart from lack of funding for health, they have also faced intermittent strikes by health care workers over deteriorating working conditions.

At the height of the Covid-19 lockdown in March, health workers including nurses and doctors went on strike for three months, which left public health institutions operating with skeletal staff during a global pandemic.

They led boycotts over the lack of medicines at hospitals and poor provision of personal protective equipment.

Advertisement

During the same period, many health workers also exited the country to seek greener pastures in European countries.

But there are fears that many people died in their homes from chronic diseases such as cancer, malaria, HIV\Aids as health facilities turned patients away, meaning these deaths would have gone unreported, according to Zimbabwe Nurses Association (Zina) president Innocent Dongo.

The collapse of the health system has also fueled clashes between health care workers and the government.

Advertisement

Zimbabwe’s Vice President Constantino Chiwenga, who is also the Health and Child Care minister, ordered the sacking of nearly 1500 nurses in November last year for rejecting his ministry’s cancellation of flexi hours for nurses.

Under the arrangement introduced a year-ago, following complaints by health workers that they cannot afford transport fares to work on their meagre salaries, hospitals introduced a two-day working week for nurses.

But the Health and Child Care ministry in memo to heads of public hospitals said the introduction of flexi hours had resulted in a lack of “continuity of nursing care in hospitals, compromised quality of patient care and exaggerated shortage of nurses resulting in inadequate ward coverage.”

Advertisement

Through their union, (Zina), the health workers have since gone to court about the issue.

But the strikes, boycotts, and limited resources, as well as Covid-19, have all led to reduced prevention programmes in the traditional hotspots of chronic illnesses such as Matabeleland North province, according to Rusike.

According to the International Agency for Research on Cancer, the most frequently occurring cancer among Zimbabweans is cervical cancer, followed by breast cancer. Among women alone, cervical cancer made up 28.9 percent of cancers in 2018, while breast cancer accounted for 17.1 percent

Advertisement

For men, the most common cancer is prostate cancer, which accounted for 20.1 percent of all cancers in 2018, followed by kaposi sarcoma, a form of skin cancer, at 15.2 percent.

According to Zimbabwe’s Registry, from 6 548 registered cases of cancer in 2013, figures shot up to 17 465 in 2018.

Meanwhile, VP Chiwenga, recently said plans were still afoot to create the Universal Health Cover that will exist side by side with medical aid societies to cushion chronically ill patients like Mhlanga  Ngulube.

Advertisement

 

 

 

Advertisement

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

National

World AIDS Day: UN Chief says ending AIDS by 2030 “is within grasp”

Published

on

BY SONIA HLOPHE

United Nations Secretary-General António Guterres has marked World AIDS Day with a message urging world leaders to scale up investment, confront stigma and ensure that lifesaving HIV services reach everyone who needs them.

Advertisement

In his statement, Guterres said this year’s commemoration serves as a reminder that the world “has the power to transform lives and futures, and end the AIDS epidemic once and for all.”

He highlighted the major gains achieved over the past decade.

“The progress we have made is undeniable,” he said, noting that “since 2010, new infections have fallen by 40 per cent” while “AIDS-related deaths have declined by more than half.” Access to treatment, he added, “is better than ever before.”

Advertisement

But despite this global progress, the Secretary-General warned that the crisis is far from over.

“For many people around the world, the crisis continues,” he said. “Millions still lack access to HIV prevention and treatment services because of who they are, where they live or the stigma they endure.”

Guterres also raised concern over shrinking resources:

Advertisement

“Reduced resources and services are putting lives at risk and threatening hard-won gains.”

He said ending AIDS requires fully supporting communities, scaling up prevention and ensuring treatment for everyone.

“Ending AIDS means empowering communities, investing in prevention and expanding access to treatment for all people.”

Advertisement

He also called for innovation to be matched by real-world delivery:

“It means uniting innovation with action, and ensuring new tools like injectables reach more people in need.”

Above all, he stressed the need for a human-rights centred response so no one is excluded.

Advertisement

“At every step, it means grounding our work in human rights to ensure no one is left behind.”

With the 2030 global deadline approaching, the UN chief said success is still possible if momentum is sustained.

“Ending AIDS as a public health threat by 2030 is within grasp. Let’s get the job done.”

Advertisement

 

Advertisement
Continue Reading

National

Zimbabwe fast-tracks approval of long-acting HIV prevention drug Lenacapavir

Published

on

BY WANDILE TSHUMA

Zimbabwe has taken a major step in the fight against HIV following the rapid approval of Lenacapavir, a groundbreaking long-acting injectable for HIV pre-exposure prophylaxis (PrEP). The Medicines Control Authority of Zimbabwe (MCAZ) authorised the drug in just 23 days, marking one of the fastest regulatory approvals in the country’s history.

Advertisement

The application, submitted by pharmaceutical company Gilead Sciences in October, underwent an expedited review because of its public health importance. MCAZ says the fast-tracked process did not compromise scientific scrutiny, with the product subjected to a rigorous assessment of its safety, efficacy and quality.

Lenacapavir is designed for adults and adolescents weighing at least 35kg who are HIV-negative but at substantial risk of infection. Unlike traditional daily oral PrEP, the medicine is administered as a six-monthly injection, following an initiation phase that includes one injection and oral tablets on Days 1 and 2. Health authorities say this long-acting formulation could dramatically improve adherence and expand prevention options, particularly for communities where daily pill-taking is difficult.

MCAZ Director-General  Richard T. Rukwata described the approval as a landmark moment in Zimbabwe’s HIV response.

Advertisement

“The rapid approval of Lenacapavir reflects MCAZ’s dedication to accelerating access to trusted, high-quality health products. This milestone brings new hope for HIV prevention and reinforces our commitment to safeguarding public health,” he said.

To fast-track the process, the Authority applied a regulatory reliance approach, drawing on scientific assessments from the World Health Organization’s Prequalification Programme (WHO PQ). This allowed evaluators to build on internationally recognised review processes while ensuring Zimbabwe’s own standards were met.

The introduction of Lenacapavir comes as Zimbabwe continues efforts to reduce new HIV infections, particularly among young people and key populations who face barriers to consistent PrEP use. Public health experts say the drug’s twice-yearly dosing could be a game changer in improving uptake and protection.

Advertisement

MCAZ says it remains committed to ensuring Zimbabweans have access to safe, effective and good-quality medical products, in line with its mandate under the Medicines and Allied Substances Control Act.

Advertisement
Continue Reading

National

Zimbabwe makes gains against TB

Published

on

BY WANDILE TSHUMA

The World Health Organization (WHO) data show that Zimbabwe continues to make measurable gains in its fight against tuberculosis (TB).

Advertisement

According to the Global Tuberculosis Report 2025, Zimbabwe’s estimated TB incidence has declined to 203 per 100,000 population, representing a 3.8 % reduction from 2023. The report states that “TB incidence in Zimbabwe has fallen to 203 per 100 000, a 3.8 % reduction from 2023.” 

On treatment outcomes, the country’s overall success rate for all forms of TB has improved to 91 %, up from 89 % in 2023. The report quotes: “Treatment success for all forms of TB has improved to 91 %, up from 89 % in 2023.” 

For drug-resistant TB (DR-TB), progress has also been recorded: treatment success rose from 64 % for the 2021 cohort to 68 % for the 2022 cohort. As the report notes: “treatment success for drug-resistant TB increased from 64 % for the 2021 cohort to 68 % for the 2022 cohort.” 

Advertisement

In the critical sphere of TB‐HIV co-infection, Zimbabwe saw a drop in the co‐infection rate to 49 %, down from 51 %. The report states: “TB/HIV co-infection rates have fallen to 49 %, down from 51 %.” 

Zooming out, the 2025 global report shows that across the world TB is falling again, although not yet at the pace required to meet targets. Globally, incidence declined by almost 2 % between 2023 and 2024, and deaths fell around 3 %. 

However, the report warns that progress is fragile. Funding shortfalls, health-system disruptions (especially during the COVID-19 era), and the ongoing challenge of drug-resistant TB threaten to erode gains. The WHO page reminds that the 2025 edition “provides a comprehensive … assessment of the TB epidemic … at global, regional and country levels.” 

Advertisement

For example, although more people are being diagnosed and treated than in previous years, not enough are being reached with preventive interventions, and many countries are still far from the targets set under the End TB Strategy.

 

Advertisement
Continue Reading

Trending

Copyright © 2022 VicFallsLive. All rights reserved, powered by Advantage